Back

Insulin resistance assessed by estimated glucose disposal rate predicts cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: a prospective cohort study

1 September 2025 (12:10 - 12:20)
Organised by: Logo
Congress Presentation Part of: Metabolic drivers of cardiovascular disease Metabolic Syndrome, Insulin, Insulin Resistance ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hao Zhang

Beijing (China)

5 More presentations in this session

Presentation thumbnail
Cardiovascular-kidney-metabolic syndrome and association with mortality in the UK Biobank prospective cohort study
Doctor K. Mayne (Glasgow, GB)
Abstract Slides
Presentation thumbnail
Transition of body mass index status from childhood to adulthood and cardiovascular-kidney-metabolic syndrome in midlife: a 36-year prospective cohort study
Doctor Y. Wang (Xi'an, CN)
Abstract Slides
Presentation thumbnail
Association of abdominal obesity with metabolic multimorbidity and death across glycemic spectrum
Doctor J. Li (Beijing, CN)
Abstract Slides
Presentation thumbnail
Prediabetes and risk of cardiovascular disease among 1.3 million patients from an integrated health care system
Doctor J. Rana (Oakland, US)
Abstract Slides
Presentation thumbnail
Additive interaction of insulin sensitivity and age on new-onset cardiovascular disease: a national population-based cohort study
Doctor Z. Lin (Shanghai, CN)
Abstract Slides

Access the full session

Session thumbnail
Metabolic drivers of cardiovascular disease
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 12:10 CET
You may be interested in
thumbnail
Congress Presentation
Additive interaction of insulin sensitivity and age on new-onset cardiovascular disease: a national population-based cohort study
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and association with mortality in the UK Biobank prospective cohort study
thumbnail
Congress Session
Cardio-renal-metabolic conundrum in heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources